Cancer immunotherapy has transformed treatment for many patients, yet its success remains uneven. Tumors that appear highly vulnerable to immune...

A large study of men with prostate cancer has put a sharper focus on a side of modern cancer treatment...

A new analysis of prostate cancer care in the United States suggests that focal therapy—an approach designed to destroy only...

For years, CAR-T cell therapy has stood as one of cancer medicine’s most striking successes. By removing a patient’s T...

For men with localized intermediate-risk prostate cancer, a high-tech radiation treatment that can complete therapy in just a few sessions...

Pittsburgh researchers have uncovered a striking mismatch between the patients receiving focal therapy for prostate cancer and the men for...

A major shift in how prostate cancer is managed across the US Department of Veterans Affairs health system has allowed...

ITHACA, N.Y. — A Cornell University-led research team has developed a chemical strategy for mapping the molecular surroundings of one...

Personalized cancer vaccines are moving from an experimental promise toward a more structured form of immunotherapy, but the field still...

Head and neck cancers may respond far more dramatically to a preoperative treatment strategy that combines chemotherapy with immunotherapy than...